HIGHLIGHTS
- who: Pierce K. H. Chow and colleagues from the Yangon Gastrointestinal and Liver Centre, Yangon, Myanmar, Selayang Hospital, Selangor, Malaysia, Seoul National University Bundang Hospital, Bundang, South have published the Article: Multicenter Phase II Study of Sequential Radioembolization-Sorafenib Therapy for Inoperable Hepatocellular Carcinoma, in the Journal: PLOS ONE | www.plosone.org of March/10,/2014
- what: This study shows the potential efficacy and manageable toxicity of sequential radioembolization-sorafenib. The nature and frequency of serious adverse events observed in this study are not unexpected for this population of HCC patients with advanced disease against . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.